Cholangiocarcinoma (CCA) is a relatively rare malignant and lethal tumour derived from bile duct epithelium and the morbidity is now increasing worldwide. This disease is difficult to diagnose at its inchoate stage and has poor prognosis. There- 
disease. [2] [3] [4] CCA is a devastating and aggressive disease that has dismal outcomes due to its late clinical presentation and stubborn resistance to chemotherapy. Surgical treatment is currently the first clinical choice for treating CCA, 1 but the treatment efficiency is low, yielding a poor prognosis and a low 5-year survival rate of 23.7%
and the recurrence rate is high. 5 In accordance with previous research, tumour cells are dedicated to build their own favourable context by incorporating extracellular matrix, stromal cells that secret tumour-related mediators, and tumour angiogenesis that provides more blood supply for tumour growth. Hence, tumour microenvironment promotes proliferation of tumour cells, assists tumours to escape from anti-tumour immune reactions, and enhances the resistance of tumour cells to treatment. 6 A study by Leyva-Illades et al.
showed that CCA cells can promote formation of surrounding connective tissue under the support from an abundant tumour microenvironment, and this process contributes prominently to therapeutic resistance of CCA. 7 Maurizio Romano and colleagues reported that the angiogenesis, metastasis, invasion, and occurrence of CCA are closely related to the tumour microenvironment and can be regulated by the interaction between CCA stem cells (a component of CCA stromal cells) and tumour microenvironment. like cyclin D1 and c-Myc. [11] [12] [13] In support of the notion that Wnt signalling promotes CCA tumourigenesis, Liu et al. confirmed that activated GSK-3β acts as an important mediator in the inhibition of CCA cells based on experimental studies. 14 In addition, a number of chemicals were found to have anti-CCA effects via suppressing the Wnt/β-catenin signalling pathway, indirectly confirming the role of this pathway in tumourigenesis of CCA. 9, 15 Another crucial signalling pathway contributing to CCA is nuclear factor kappa B (NF-κB) signalling pathway. NF-κB, which binds to its inhibitor IκB in unstimulated cells, is activated when IκB is phosphorylated by the protein kinase of IκBs (IKK) or ubiquitnated by SCF-E3 and degraded by protease. Activated NF-κB enters the nucleus and binds to DNA to induce the transcription of target genes, thus modulating the growth and development of CCA. 16 Performed with a series of in vitro experiments, Srikoon et al. revealed that the inhibition of NF-κB signalling pathway impedes CCA metastasis and migration via suppressing the transcription of its target genes that express intercellular cell adhesion molecules in CCA cell lines. 17 What's more, a growing number of substances have been found to inhibit CCA by blocking NF-κB signalling pathway like Magnolol, 18 Berberine, 19 Caffeic acid phenethyl ester, 20 and beta-eudesmo. 21 The above evidence indirectly demonstrates the importance of NF-κB signalling pathway in the development of CCA. The notch signalling pathway also plays an important role in CCA progression. Binding of notch ligands and receptors induce the shear of notch protein, and then the generated notch intracellular domain (NICD) enters the nucleus to form a complex with transcription factor CLS (a kind of DNA-binding protein), 22 which activates the expression of CCAinducing target gene. 23 DSL family members act as notch ligands, of which Jagged 1 is one of the most significant CCA-associated notch ligands, 24 and Notch2 receptors have a close relationship with CCA. 25 The activation of notch signalling together with the inactiva- and breast tumour models. 35 As for CCA, hypoxia modulates the genes expression to influence the production of proteins which are associated with cell cycle, apoptosis, cellular movement in CCA cells. and S100 calcium binding protein P (S100P), thus promoting CCA invasion and proliferation. 36 And the invasion of CCA also can be enhanced by hypoxia through hepatocyte growth factor receptor (Met)/extracellular signalregulated kinase (ERK) pathway. 37 In addi- forin that is critical in the anticancer activities. 43 Development and metastasis of CCA is also modulated by CCA-derived exosomes which can transfer oncogenic proteins, and oncogenic proteins can accelerate tumour progression by inducing β-catenin and reducing E-cadherin expressions in CCA cells. 44 
| Chronic inflammation and cytokines
An increasing number of research findings have confirmed Rudolf
Virchow's postulation that tumours evolve from chronic inflammation. 45 As a very common and important basic pathological process, growth of CCA by Akt/NF-κB signalling which enhances the expression of metal matrix proteinase (MMP). 59 As an upstream activator of STAT3, IL-6 induces malignant transformation and metastasis of CCA. 60 In addition, TNF-α can regulate EMT to accelerate CCA invasion. 61 Taken together, interleukin, growth factors, chemokines, proangiogenic factors, and modifying enzymes secreted by CCA CHEN ET AL.
| 63 stromal cells establish a network of cytokines to impact CCA progression.
| Fibroblasts
Through genetic lineage tracing and transplantation assays, Rinkevich et al. confirmed that fibroblasts are related to the formation of cancer stroma. 62 Fibroblasts are recruited to the CCA tumourigenic region and transformed into "active fibroblasts" or CCA associated fibroblasts which make up a large proportion of CCA stromal cells.
CCA associated fibroblasts can induce the proliferation and invasion of CCA by producing alpha-smooth actin (α-SMA), fibroblast-specific protein-1, fibroblast activation protein, and PDGFR-β. 63 further demonstrated that CD8+ T lymphocytes were present in CCA.
And it is not CD8+ T lymphocytes but memory type CD8+ T lymphocytes (CD8+CD45RO+) that are important for the prognosis of CCA. 100 Besides, programmed cell death ligand 1 (PD-L1), a protein that can be expressed on CCA cells 100 and the stromal cells of CCA, is highly expressed in the area where there are abundant tumour infiltrating T lymphocytes in CCA. 101 High expression of PD-L1 is associated with poor prognosis of CCA which support the potential rationale of using PD-1 blockade immunotherapy in CCA. 
| FUTURE DIRECTION AND OUTLOOK
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